EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:74440 - epidermal growth factor receptor antagonist
| ChEBI ID | CHEBI:74440 |
| ChEBI Name | epidermal growth factor receptor antagonist |
| Stars | |
| Definition | An antagonist at the epidermal growth factor receptor. |
| Last Modified | 31 January 2025 |
| Submitter | namrata |
| Wikipedia |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| epidermal growth factor receptor antagonist (CHEBI:74440) is a antagonist (CHEBI:48706) |
| epidermal growth factor receptor antagonist (CHEBI:74440) is a protein kinase inhibitor (CHEBI:37699) |
| Incoming Relation(s) |
| N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}but-2-ynamide (CHEBI:90180) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| 2-(3,4-dimethoxyphenyl)-9-[3-methyl-4-(4-methylpiperazin-1-yl)phenyl]purine-6-carboxamide (CHEBI:194300) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| AEE788 (CHEBI:40629) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| BI-4020 (CHEBI:232716) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| dacomitinib (CHEBI:132268) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| erlotinib (CHEBI:114785) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| gefitinib (CHEBI:49668) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| osimertinib (CHEBI:90943) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| osimertinib mesylate (CHEBI:90948) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| PD 168393 (CHEBI:131504) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| PD-153035 (CHEBI:91076) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| PD-153035 hydrochloride (CHEBI:91075) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| poziotinib (CHEBI:195559) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| sapitinib (CHEBI:132986) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| semicochliodinol A (CHEBI:66461) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| semicochliodinol B (CHEBI:66462) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| tesevatinib (CHEBI:167674) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| tyrphostin AG 1478 (CHEBI:75404) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| tyrphostin AG 825 (CHEBI:75405) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| varlitinib (CHEBI:231356) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| zipalertinib (CHEBI:233402) has role epidermal growth factor receptor antagonist (CHEBI:74440) |
| Synonyms | Source |
|---|---|
| EGFR antagonoist | ChEBI |
| EGFR antagonoists | ChEBI |
| EGFR inhibitor | ChEBI |
| EGFR inhibitors | ChEBI |
| epidermal growth factor receptor antagonists | ChEBI |
| epidermal growth factor receptor inhibitor | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Epidermal_growth_factor_receptor | Wikipedia |